Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Broderick

Showing results (111-120 of 131) with videos related to

Pageof 14
Sort By:
Pediatrics|January 3, 2001
The impact of a clinic-based literacy intervention on language development in inner-city preschool childrenA L Mendelsohn, L N Mogilner, B P Dreyer, et al.
The American Journal of Cardiology|September 1, 1999
Time course, magnitude, and consistency of platelet inhibition by abciximab, tirofiban, or eptifibatide in patients with unstable angina pectoris undergoing percutaneous coronary interventionD J Kereiakes, T M Broderick, E M Roth, et al.
Circulation|August 19, 1997
Sustained platelet glycoprotein IIb/IIIa blockade with oral xemilofiban in 170 patients after coronary stent deploymentD J Kereiakes, N Kleiman, J J Ferguson, et al.
Nano Letters|April 22, 2025
Precise Fabrication of Graphite-Like Material Directly on a Biological Membrane Enabled by Ethanol Ice ResistDylan A Chiaro, Travis J Hager, Kyle T Renshaw, et al.
Journal of Thrombosis and Thrombolysis|December 30, 1999
High platelet count in platelet-rich plasma reduces measured platelet inhibition by abciximab but not tirofiban nor eptifibatide glycoprotein IIb/IIIa receptor antagonistsD J Kereiakes, T M Broderick, E M Roth, et al.
American Heart Journal|March 7, 2001
Dalteparin in combination with abciximab during percutaneous coronary interventionD J Kereiakes, N S Kleiman, E Fry, et al.
Nature Structural & Molecular Biology|June 29, 2010
Structure of Rev-erbalpha bound to N-CoR reveals a unique mechanism of nuclear receptor-co-repressor interactionCaroline A Phelan, Robert T Gampe, Millard H Lambert, et al.
The Journal of Invasive Cardiology|April 2, 2003
Durable clinical benefit following Sr90 Beta irradiation therapy for in-stent restenosis in high-volume community practiceJohn J Young, Daniel P Marcus, Charles W Abbottsmith, et al.
The Annals of Thoracic Surgery|December 13, 2021
Impact of Chest Wall Resection on Mortality After Lung Resection for Non-Small Cell Lung CancerChristopher W Towe, Elliot L Servais, Maria Grau-Sepulveda, et al.
The Journal of Invasive Cardiology|April 14, 2000
Combination enoxaparin-abciximab therapy during coronary intervention: the next standard of care?D A Tramuta, D J Kereiakes, E J Dippel, et al.
Pageof 14

Showing results (111-120 of 131) with videos related to

Sort By:
Pageof 14
Pediatrics|January 3, 2001
The impact of a clinic-based literacy intervention on language development in inner-city preschool childrenA L Mendelsohn, L N Mogilner, B P Dreyer, et al.
The American Journal of Cardiology|September 1, 1999
Time course, magnitude, and consistency of platelet inhibition by abciximab, tirofiban, or eptifibatide in patients with unstable angina pectoris undergoing percutaneous coronary interventionD J Kereiakes, T M Broderick, E M Roth, et al.
Circulation|August 19, 1997
Sustained platelet glycoprotein IIb/IIIa blockade with oral xemilofiban in 170 patients after coronary stent deploymentD J Kereiakes, N Kleiman, J J Ferguson, et al.
Nano Letters|April 22, 2025
Precise Fabrication of Graphite-Like Material Directly on a Biological Membrane Enabled by Ethanol Ice ResistDylan A Chiaro, Travis J Hager, Kyle T Renshaw, et al.
Journal of Thrombosis and Thrombolysis|December 30, 1999
High platelet count in platelet-rich plasma reduces measured platelet inhibition by abciximab but not tirofiban nor eptifibatide glycoprotein IIb/IIIa receptor antagonistsD J Kereiakes, T M Broderick, E M Roth, et al.
American Heart Journal|March 7, 2001
Dalteparin in combination with abciximab during percutaneous coronary interventionD J Kereiakes, N S Kleiman, E Fry, et al.
Nature Structural & Molecular Biology|June 29, 2010
Structure of Rev-erbalpha bound to N-CoR reveals a unique mechanism of nuclear receptor-co-repressor interactionCaroline A Phelan, Robert T Gampe, Millard H Lambert, et al.
The Journal of Invasive Cardiology|April 2, 2003
Durable clinical benefit following Sr90 Beta irradiation therapy for in-stent restenosis in high-volume community practiceJohn J Young, Daniel P Marcus, Charles W Abbottsmith, et al.
The Annals of Thoracic Surgery|December 13, 2021
Impact of Chest Wall Resection on Mortality After Lung Resection for Non-Small Cell Lung CancerChristopher W Towe, Elliot L Servais, Maria Grau-Sepulveda, et al.
The Journal of Invasive Cardiology|April 14, 2000
Combination enoxaparin-abciximab therapy during coronary intervention: the next standard of care?D A Tramuta, D J Kereiakes, E J Dippel, et al.
Pageof 14